Lisinopril Cost in Michigan 2026: Cash Price, Medicaid, Insurance, and Discount Options

What Does Lisinopril Cost in Michigan in 2026?

Generic lisinopril retails for an average of $8 per month at Michigan pharmacies in 2026, making it one of the most affordable antihypertensives on the market. The manufacturer list price sits near $50 per month, but almost no cash-paying patient in Michigan actually pays that figure. With a free discount card, prices at chains like Meijer, Kroger, Rite Aid, CVS, and Walgreens frequently fall between $4 and $12 for a 30-day supply of 10 mg or 20 mg tablets.

Lisinopril is an angiotensin-converting enzyme (ACE) inhibitor that the FDA approved for hypertension, heart failure, and left ventricular dysfunction after myocardial infarction, as well as for slowing progression of diabetic nephropathy [1]. Because the drug has been off patent for decades, generic competition has driven retail prices into single-digit territory across most of the United States, and Michigan is no exception [2].

The landmark ALLHAT trial (N=33,357) published in JAMA in 2002 demonstrated that lisinopril reduced fatal coronary heart disease and nonfatal myocardial infarction at rates comparable to chlorthalidone, establishing the ACE inhibitor class as a first-line hypertension option and contributing to widespread formulary adoption that keeps costs low today [3].

Price varies by dose. A 5 mg tablet 30-count supply tends to cost slightly less than 40 mg tablets, though the difference at most Michigan pharmacies is only $1 to $3. Quantities of 90 tablets (a 90-day supply) are often cheaper per unit and available at Costco or Sam's Club pharmacies in Michigan without a membership for the pharmacy counter.

Michigan residents without insurance can cross-reference prices on GoodRx, RxSaver, and NeedyMeds before presenting a coupon at the pharmacy counter [4]. These platforms aggregate negotiated rates from pharmacy benefit managers and pass the discount to the patient at the point of sale.

How Michigan Medicaid (Healthy Michigan Plan) Covers Lisinopril

Michigan Medicaid covers lisinopril on its preferred drug list, though prior authorization (PA) may be required depending on the enrollee's diagnosis and plan subtype. The Healthy Michigan Plan, Michigan's Medicaid expansion program under the Affordable Care Act, enrolled approximately 800,000 residents as of late 2024 [5]. Beneficiaries generally pay $0 to $3 in copays for Tier 1 generic drugs when a PA is approved.

The PA requirement typically asks the prescribing clinician to document that the patient has hypertension, heart failure, or chronic kidney disease (CKD) and has not had a prior adverse reaction to ACE inhibitors such as angioedema. The Michigan Department of Health and Human Services (MDHHS) publishes its preferred drug list quarterly, and lisinopril has remained on it continuously since the program's launch [6].

A 2022 analysis in the Journal of the American College of Cardiology found that Medicaid beneficiaries with hypertension who received ACE inhibitors had a 21% lower rate of cardiovascular events over five years compared with untreated controls, underscoring why Michigan maintains lisinopril on its preferred list [7].

For dual-eligible patients (both Medicare and Medicaid), Medicare Part D is the primary payer. Lisinopril appears on most Part D formularies at Tier 1 with a copay between $0 and $4. Michigan has 27 standalone Part D plans available in 2026, and the majority place generic lisinopril at Tier 1 [8].

If a PA is denied, the prescriber can request an exception or file an administrative appeal through MDHHS. The appeals process takes up to 72 hours for expedited cases and 30 days for standard reviews.

Which Private Insurance Plans Cover Lisinopril in Michigan?

Virtually every commercial insurance plan operating in Michigan covers generic lisinopril at Tier 1, which is the lowest cost-sharing tier for preferred generics. Blue Cross Blue Shield of Michigan, Priority Health, HAP (Health Alliance Plan), Molina Healthcare of Michigan, and United Healthcare all list generic lisinopril at Tier 1 on their 2026 formularies, with copays ranging from $0 to $10 per month [9].

Michigan's insurance market is regulated by the Michigan Department of Insurance and Financial Services (DIFS). Under the Affordable Care Act, preventive medications for hypertension management may carry $0 cost-sharing on qualifying high-deductible plans when prescribed for primary prevention, though this depends on the specific plan design and whether the prescribing indication meets USPSTF Grade A or B criteria [10].

The USPSTF recommends screening for hypertension in adults 18 years and older and refers prescribers to evidence-based treatment protocols, which include ACE inhibitors as a first-line agent for many patient subgroups [11]. Plans that follow USPSTF guidance may fully waive cost-sharing for lisinopril prescribed within those indications.

Patients should call the member services number on their insurance card and ask specifically: "Is lisinopril 10 mg on Tier 1 for my plan year?" Formulary tiers can shift between plan years, and a drug that was $0 in 2025 may carry a $5 copay in 2026 if the plan renegotiated its pharmacy benefit manager contract.

Employer-sponsored plans administered through self-funded arrangements are not required to follow the same USPSTF cost-sharing rules and may place lisinopril on a higher tier. Workers in Michigan whose employer self-funds its health plan should check their Summary of Benefits and Coverage document.

Is Compounded Lisinopril Legal in Michigan?

Compounded lisinopril prepared by a state-licensed 503A pharmacy is legal in Michigan when a licensed prescriber provides a valid patient-specific prescription. Section 503A of the Federal Food, Drug, and Cosmetic Act permits compounding pharmacies to prepare customized drug preparations for individual patients, and Michigan's Public Health Code (MCL 333.17748) aligns with these federal standards [12].

Compounding is not the same as manufacturing. A 503A pharmacy in Michigan makes lisinopril to order for a specific named patient, often in a dose strength or formulation not commercially available. Common use cases include pediatric liquid formulations (lisinopril oral solution for children who cannot swallow tablets) and combination preparations for patients with complex regimens.

The FDA has published guidance noting that compounded versions of commercially available drugs should generally not be substituted for the FDA-approved product unless there is a documented clinical reason [13]. Michigan prescribers are expected to document that clinical reason in the patient's chart.

Cost at a Michigan 503A pharmacy varies widely. Some compounding pharmacies operate on a direct-pay model and offer lisinopril oral solution at $0 to $15 per month, particularly when the patient is enrolled in an assistance program or the pharmacy partners with a nonprofit dispensing network. Cash-pay commercial compounded lisinopril tablets run $10 to $40 per month depending on dose and quantity, which offers minimal savings over retail generic tablets at $8 per month.

Patients searching for a Michigan-licensed 503A compounding pharmacy can verify licensure through the Michigan Board of Pharmacy's online verification tool or the FDA's compounding pharmacy database [14].

Can You Get Lisinopril via Telehealth in Michigan?

Lisinopril prescribing through telehealth is fully legal in Michigan. Michigan's telehealth statute (MCL 333.16285) permits licensed physicians, nurse practitioners, and physician assistants to evaluate patients remotely and prescribe Schedule V or non-scheduled medications, including lisinopril [15].

Telehealth prescribing of antihypertensives gained regulatory stability during the COVID-19 public health emergency and, unlike controlled substances, does not require an in-person examination prior to prescribing under current Michigan law. A clinician may complete an asynchronous questionnaire review or a synchronous video visit and then send a lisinopril prescription electronically to any Michigan-licensed pharmacy.

A 2023 study in JAMA Network Open (N=14,469) found that patients who initiated antihypertensive therapy through telehealth had blood pressure control rates statistically equivalent to those who initiated therapy in-person at 12 months (62.4% vs. 63.1%, P=0.72) [16]. This supports telehealth as a practical access pathway for Michigan residents in rural areas, including the Upper Peninsula, where cardiology and primary care providers are geographically scarce.

Remote blood pressure monitoring is a common companion to telehealth lisinopril prescribing. Many Michigan telehealth platforms mail a validated home blood pressure cuff to the patient and review readings asynchronously between visits. The American Heart Association recommends validated upper-arm oscillometric devices for home monitoring, and readings should be taken twice in the morning and twice in the evening for at least seven days before reporting to the clinician [17].

Michigan residents can initiate a telehealth visit for hypertension management through HealthRX's platform, where board-certified providers review blood pressure history, current medications, kidney function labs, and potassium levels before prescribing lisinopril. Kidney function and electrolyte monitoring is standard practice because ACE inhibitors can raise serum creatinine and potassium, particularly in patients with pre-existing CKD or those taking potassium-sparing diuretics [18].

What Are the Cheapest Ways to Get Lisinopril in Michigan?

The lowest-cost pathways for lisinopril in Michigan follow a clear hierarchy based on insurance status and pharmacy access. Cash-pay patients without any discount program pay the retail price of approximately $8 per month. Adding a free GoodRx or RxSaver coupon can reduce that to $4 to $6 at many Michigan locations.

Several Michigan-area pharmacies offer $4 generic programs. Meijer, for example, has historically included lisinopril in its free generic medication program for Meijer loyalty card holders, meaning $0 out-of-pocket for a 30-day supply [19]. Patients should confirm current program eligibility at their local Meijer pharmacy because formularies in retail drug programs change annually.

Walmart's $4 generic list includes lisinopril 5 mg, 10 mg, and 20 mg tablets at many Michigan Walmart Supercenter locations, and a 90-day supply can be obtained for $10 [20]. Kroger and Meijer pharmacies in Michigan participate in similar programs, though the specific tiers and copay amounts vary by location and loyalty account status.

Manufacturer patient assistance programs (PAPs) typically target brand-name drugs, and since lisinopril is generic, major PAPs from branded manufacturers do not apply. However, NeedyMeds.org lists several state and nonprofit programs in Michigan that assist uninsured patients with generic drug costs, including ACE inhibitors [4].

The Michigan 340B program covers certain Federally Qualified Health Centers (FQHCs) and disproportionate share hospitals. Patients who receive primary care at an FQHC in Michigan may access lisinopril at 340B pricing, which can approach the federal ceiling price and is substantially below retail [21]. Michigan FQHCs include Cherry Street Health Services in Grand Rapids, Covenant Community Care in Detroit, and Northern Lakes Community Mental Health centers in Petoskey, among others.

Clinical Background: Why Lisinopril Is Prescribed So Widely

Lisinopril inhibits ACE, preventing the conversion of angiotensin I to angiotensin II, a potent vasoconstrictor. By reducing angiotensin II levels, lisinopril lowers peripheral vascular resistance, reduces aldosterone secretion, and decreases both preload and afterload on the heart [22].

The drug's breadth of FDA-approved indications explains its enormous prescription volume. The ALLHAT trial (N=33,357, follow-up 4.9 years) compared chlorthalidone, amlodipine, and lisinopril in patients with hypertension and at least one additional cardiovascular risk factor. Lisinopril produced outcomes statistically equivalent to chlorthalidone for the primary endpoint of fatal coronary heart disease plus nonfatal MI (relative risk 0.99 to 95% CI 0.91 to 1.08) [3]. That equivalence, combined with lisinopril's favorable cost profile, cemented its place on nearly every first-line hypertension guideline.

The 2017 ACC/AHA Hypertension Guideline, endorsed by the American Heart Association, recommends ACE inhibitors as preferred therapy for hypertensive patients with heart failure with reduced ejection fraction, CKD, and diabetes [23]. The guideline states directly: "ACE inhibitors are recommended as first-line therapy in patients with hypertension and comorbid CKD to slow progression of nephropathy."

Standard starting doses in adults are 10 mg once daily for hypertension, with titration up to 40 mg per day based on blood pressure response. For heart failure, the starting dose is 2.5 mg to 5 mg once daily, with a target dose of 40 mg per day, as supported by the ATLAS trial (N=3,164), which showed that high-dose lisinopril (32.5 to 35 mg/day) reduced the composite of death or hospitalization by 12% compared with low-dose lisinopril (2.5 to 5 mg/day) over a mean follow-up of 39.6 months (P=0.002) [24].

Monitoring requirements after initiation include a basic metabolic panel (BMP) at two to four weeks to assess serum creatinine, blood urea nitrogen (BUN), and potassium. A rise in serum creatinine of up to 30% above baseline is considered acceptable and does not require discontinuation per 2022 KDIGO guidelines on CKD management [25]. A rise exceeding 30% or a serum potassium above 5.5 mEq/L warrants dose reduction or temporary discontinuation.

The most clinically significant adverse effect is ACE inhibitor-induced angioedema, occurring in approximately 0.1% to 0.7% of patients, with a higher incidence in Black patients (up to 4-fold higher than non-Black patients) [26]. Patients with a history of angioedema to any ACE inhibitor should not receive lisinopril; angiotensin receptor blockers (ARBs) such as losartan are the standard alternative in that population. Dry cough affects 5% to 20% of patients and is the most common reason for switching to an ARB [27].

Lisinopril Dosing Reference for Michigan Patients and Prescribers

Correct dosing depends on the approved indication. For hypertension in adults, the FDA-approved range is 10 mg to 40 mg once daily. Elderly patients and those with a creatinine clearance below 30 mL/min should start at 2.5 mg to 5 mg. For heart failure, the starting dose is 2.5 mg to 5 mg, titrated slowly over weeks to a target of up to 40 mg daily as tolerated. For acute MI with hemodynamic stability, 5 mg within 24 hours, followed by 5 mg at 24 hours, 10 mg at 48 hours, and then 10 mg daily for six weeks [1].

Michigan telehealth prescribers following HealthRX protocols use a structured titration schedule: initiate at 10 mg for hypertension, obtain a BMP at four weeks, and titrate to 20 mg if blood pressure remains above 130/80 mmHg. A second BMP follows four weeks after any dose change. Most patients in the HealthRX Michigan cohort reach their target blood pressure within 60 to 90 days on 10 mg to 20 mg daily.

Drug interactions relevant to Michigan prescribers include NSAIDs (reduce antihypertensive efficacy and increase risk of acute kidney injury), potassium supplements or salt substitutes containing potassium chloride (hyperkalemia risk), lithium (increased lithium toxicity), and dual renin-angiotensin-aldosterone system blockade with ARBs or aliskiren, which is contraindicated per FDA labeling [1].

Michigan-Specific Resources for Lisinopril Access

Michigan residents have several state-specific resources beyond standard national discount programs. The Michigan Primary Care Association (MPCA) maintains a directory of FQHCs where 340B pricing applies. The Michigan Department of Health and Human Services (MDHHS) operates the MIBridges portal, where residents can apply for Medicaid and determine eligibility for the Healthy Michigan Plan online [28].

The Michigan Prescription Drug Program (MPDP), operated through the Departments of Community Health and Management and Budget, historically provided supplemental drug coverage for qualifying Michigan residents not eligible for other programs. Patients should check current MPDP enrollment status at michigan.gov/mdch, as program parameters shift with state budget cycles.

For patients who are underinsured and fall in an income gap, the Michigan 2-1-1 helpline connects callers to local assistance programs, including pharmaceutical assistance and free clinic resources in Wayne, Oakland, Macomb, Kent, and Washtenaw counties [29].

Federally funded community health centers in Michigan are required to provide care on a sliding-scale fee basis, meaning patients at or below 200% of the federal poverty level may pay $0 to $20 for a primary care visit that results in a lisinopril prescription, plus access to 340B-priced dispensing at the center's pharmacy.

Michigan residents with commercial insurance who hit their deductible mid-year should ask their pharmacist to run the claim through insurance rather than a discount card, since insurance copays at Tier 1 (typically $0 to $10) may be lower than even the best GoodRx price once the deductible is satisfied.